Onegene Biotechnology is taking part in the European Association for the Study of the Liver (EASL) Annual Congress,and presenting a poster, "Effe..

The week at the BIO conference in Boston was highly successful for Onegene Biotechnology. Undeniably, the conference served as an unparalleled platfor..

Onegene Biotechnology was the proud host of the Chronic Inflammation Symposium 2023, held on May 11, 2023. The event highlighted the crucial role of c..

Recently we hold a long-awaited workshop to celebrate a successful scale up of OGB21502 production.Our passionate and talented team devoted months of ..

We are excited to share that DaeSeong Im, our Chief Technology Officer (CTO), invited to the Australia Biologics Festival (ABF) 2023, hosted by IMPAC ..

Our deepest sympathies go out to all those who have been affected by the recent earthquakes that have caused extensive damage in Türkiye.Our hearts ar..

Onegene Biotechnology is thrilled to announce our CEO, SungJin Park, and members of our Business Development team will be at the upcoming 2023 JP Morg..

Onegene Biotechnology is excited to win “Next Technology” award, granted to Korean startups those lead innovative future technologies & trends, at..

Onegene Biotechnology to present at Bio Japan(Yokohama, Oct. 12-14) on Multi-specific drug platform UniStac® and OGB21502, the first UniStac® based Te..

Last week, SJ Park, Ph. D., CEO of Onegene Biotechnology, gave a lecture on Unistac® platform, next generation of multi-specific antibody, at ASK(The ..